Cargando…
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Prior to coronavirus disease 2019 (COVID-19), tuberculosis (TB) was the worst killer among infectious diseases. The union of these two obnoxious respiratory diseases can be devastating, with severe public health implications. The COVID-19 pandemic has affected all TB-elimination programmes due to th...
Autores principales: | Shariq, Mohd, Sheikh, Javaid A., Quadir, Neha, Sharma, Neha, Hasnain, Seyed E., Ehtesham, Nasreen Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488123/ https://www.ncbi.nlm.nih.gov/pubmed/35418488 http://dx.doi.org/10.1183/16000617.0264-2021 |
Ejemplares similares
-
Mycobacterium tuberculosis protein MoxR1 enhances virulence by inhibiting host cell death pathways and disrupting cellular bioenergetics
por: Quadir, Neha, et al.
Publicado: (2023) -
Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival
por: Sharma, Neha, et al.
Publicado: (2021) -
Mycobacterium tuberculosis RipA Dampens TLR4-Mediated Host Protective Response Using a Multi-Pronged Approach Involving Autophagy, Apoptosis, Metabolic Repurposing, and Immune Modulation
por: Shariq, Mohd, et al.
Publicado: (2021) -
Learning from COVID-19 to tackle TB pandemic: From despair to hope
por: Sheikh, Javaid Ahmad, et al.
Publicado: (2022) -
Disorder‐to‐order transition in PE–PPE proteins of Mycobacterium tuberculosis augments the pro‐pathogen immune response
por: Ahmad, Javeed, et al.
Publicado: (2019)